Topic: Cardiovascular Medicine

Barbara Walters returns to 'The View,' greeted by fellow heart surgery patient David LettermanBarbara Walters says that she's feeling fine after heart surgery in May and that she has practically no scar. Walters got a rousing welcome Tuesday as she returned to ...

Abbott diet drug study renews calls for U.S. ban

WASHINGTON (Reuters) - A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market. Final data from the so-called SCOUT ...

Corrected: Abbott's diet drug study renews calls for U.S. ban

WASHINGTON (Reuters) - A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market. Final data from the so-called SCOUT ...
Medical journal editors question sale of diet pill; study shows it raises heart risks in someEditors of a top medical journal call Meridia "another flawed diet pill" and question whether it should stay on the market as a study shows it raises ...

Gaining on death, cooling therapy catches on

PHILADELPHIA (Reuters Health) - It was a cold, drizzly March morning this year when Ed Sproull's heart stopped beating. At 58, he had arrived at work feeling fit and healthy. As he stepped into the elevator at De Lage Landen Financial Services ...

Heart pill 'could save 10,000 lives a year'

A pill for chest pains costing £10 a week could save the lives of thousands of heart failure patients and dramatically reduce hospital admissions, trial results published Monday suggest. Professor Martin Cowie, who led the UK-based part of the study, said the ...

European guidelines back use of Sanofi's Multaq

STOCKHOLM (Reuters) - Sanofi-Aventis's recently launched heart rhythm drug Multaq should be considered as a treatment option for patients with atrial fibrillation, a common arrhythmia, according to new medical guidelines. Multaq, or dronedarone, was designed as a improvement on the older drug ...

Gaining on death, cooling therapy catches on slowly

PHILADELPHIA (Reuters Health) - It was a cold, drizzly March morning this year when Ed Sproull's heart stopped beating. At 58, he had arrived at work feeling fit and healthy. As he stepped into the elevator at De Lage Landen Financial Services ...

Heart risk factors a growing problem in Mexico

NEW YORK (Reuters Health) - Large percentages of Mexican adults have risk factors for heart disease and stroke -- suggesting, researchers say, that without intervention, the nation's rate of cardiovascular disease will continue the climb it began several decades ago. In a ...

IBM launches cardiovascular disease management system in China

HONG KONG (Reuters) - International Business Machines Corp (IBM) on Thursday announced the launch of China's first all-in-one electronic cardiogram management system aimed at improving the detection and management of cardiovascular diseases. IBM said it had teamed up with Chinese electronic cardiogram ...
Previous